174 related articles for article (PubMed ID: 24448453)
1. Managing the innovation supply chain to maximize personalized medicine.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2014 Feb; 95(2):113-8. PubMed ID: 24448453
[TBL] [Abstract][Full Text] [Related]
2. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2017 Jan; 101(1):8-12. PubMed ID: 27869291
[TBL] [Abstract][Full Text] [Related]
3. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
4. Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.
Özdemir V; Arga KY; Aziz RK; Bayram M; Conley SN; Dandara C; Endrenyi L; Fisher E; Garvey CK; Hekim N; Kunej T; Şardaş S; Von Schomberg R; Yassin AS; Yılmaz G; Wang W
OMICS; 2020 Feb; 24(2):62-80. PubMed ID: 32027574
[TBL] [Abstract][Full Text] [Related]
5. Bridging the Gaps in Personalized Medicine Value Assessment: A Review of the Need for Outcome Metrics across Stakeholders and Scientific Disciplines.
Bush WS; Cooke Bailey JN; Beno MF; Crawford DC
Public Health Genomics; 2019; 22(1-2):16-24. PubMed ID: 31454805
[TBL] [Abstract][Full Text] [Related]
6. Health technology assessment in the era of personalized health care.
Becla L; Lunshof JE; Gurwitz D; Schulte In den Bäumen T; Westerhoff HV; Lange BM; Brand A
Int J Technol Assess Health Care; 2011 Apr; 27(2):118-26. PubMed ID: 21450126
[TBL] [Abstract][Full Text] [Related]
7. Policy perspectives on the emerging pathways of personalized medicine.
Downing GJ
Dialogues Clin Neurosci; 2009; 11(4):377-87. PubMed ID: 20135895
[TBL] [Abstract][Full Text] [Related]
8. Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.
Pasipoularides A
Int J Cardiol; 2017 Mar; 230():384-401. PubMed ID: 28057368
[TBL] [Abstract][Full Text] [Related]
9. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
[TBL] [Abstract][Full Text] [Related]
10. Making the Most of Innovation in Personalised Medicine: An EU Strategy for a Faster Bench to Bedside and Beyond Process.
Horgan D; Lal JA
Public Health Genomics; 2018; 21(3-4):101-120. PubMed ID: 30947224
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology: a paradigm for individualized medicine.
Waldman SA; Kraft WK; Nelson TJ; Terzic A
Biomark Med; 2009 Dec; 3(6):679-84. PubMed ID: 20477706
[TBL] [Abstract][Full Text] [Related]
12. Innovation in healthcare. The challenge for laboratory medicine.
Price CP; St John A
Clin Chim Acta; 2014 Jan; 427():71-8. PubMed ID: 24113488
[TBL] [Abstract][Full Text] [Related]
13. Practice innovation: the need for nimble data platforms to implement precision oncology care.
Elfiky A; Zhang D; Krishnan Nair HK
Discov Med; 2015; 20(108):27-32. PubMed ID: 26321084
[TBL] [Abstract][Full Text] [Related]
14. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
[TBL] [Abstract][Full Text] [Related]
15. Genomic and personalized medicine: foundations and applications.
Ginsburg GS; Willard HF
Transl Res; 2009 Dec; 154(6):277-87. PubMed ID: 19931193
[TBL] [Abstract][Full Text] [Related]
16. The revolution of personalized psychiatry: will technology make it happen sooner?
Perna G; Grassi M; Caldirola D; Nemeroff CB
Psychol Med; 2018 Apr; 48(5):705-713. PubMed ID: 28967349
[TBL] [Abstract][Full Text] [Related]
17. Process Improvement for Maximized Therapeutic Innovation Outcome.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2018 Jan; 103(1):8-12. PubMed ID: 29265398
[TBL] [Abstract][Full Text] [Related]
18. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
Tsimberidou AM; Ringborg U; Schilsky RL
Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
[TBL] [Abstract][Full Text] [Related]
19. Personalized lifestyle medicine: relevance for nutrition and lifestyle recommendations.
Minich DM; Bland JS
ScientificWorldJournal; 2013; 2013():129841. PubMed ID: 23878520
[TBL] [Abstract][Full Text] [Related]
20. Managing customization in health care: a framework derived from the services sector literature.
Minvielle E; Waelli M; Sicotte C; Kimberly JR
Health Policy; 2014 Aug; 117(2):216-27. PubMed ID: 24837516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
